Live
- Most Americans not aware that alcohol ups cancer risk: Survey
- Bengal bypolls: Trinamool Congress sweeps up all six Assembly constituencies, Mamata thanks voters (4th Lead)
- BJP wins five Rajasthan bypolls seats, Congress one
- VHP's 'Sant Samavesh' discusses Waqf issue, religious conversions, autonomy for temples
- Famous Chinar boat race organised in J&K's Dal Lake
- Entire Maharashtra behind PM Modi: Devendra Fadnavis
- Tragic Road Accident in Anantapur District Claims Four Lives
- I bow down to voters' decision: Kumaraswamy’s son on bypolls defeat
- Priyanka's resemblance with Indira Gandhi only in appearance: Robert Vadra
- NDA predicts victory in 2025 Assembly elections after winning Bihar bypolls
Hetero Labs arm acquires Spanish firm
Hetero, one of Indias leading generic pharmaceutical companies and the worlds largest producer of antiretroviral drugs, announced on Wednesday that its European subsidiary Amarox Limited has acquired Tarbis Farma, a company operating in Spain from Grupo Ferrer Internacional
​Hyderabad: Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced on Wednesday that its European subsidiary Amarox Limited has acquired Tarbis Farma, a company operating in Spain from Grupo Ferrer Internacional.
Tarbis Farma comes with a robust product portfolio and an extensive marketing network with well-experienced personnel in retail business across Spain. The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio, manpower and a seamless entry into the retail, hospital and Tender business channels in Spain.
A V Narasa Reddy, ED, Hetero Labs Limited, stated that this acquisition fits very well with Hetero’s growth strategy in EU giving Amarox a platform to reach out to the customers in a robust way with the present portfolio and Hetero’s pipeline
of products.
